# Antibiotics During Intrauterine Balloon Tamponade Placement

> **NCT03478163** · PHASE4 · TERMINATED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 11 (actual)

## Conditions studied

- Obstetric Complication
- Postpartum Hemorrhage
- Postpartum Endometritis

## Interventions

- **DRUG:** CeFAZolin 1000 MG
- **DRUG:** Clindamycin 900 MG in 6 ML Injection

## Key facts

- **NCT ID:** NCT03478163
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-03-08
- **Primary completion:** 2021-05-03
- **Final completion:** 2021-05-03
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Problems with recruitment
- **Last updated:** 2021-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03478163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03478163, "Antibiotics During Intrauterine Balloon Tamponade Placement". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03478163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*